Watson recalls one Propafenone HCL lot

Watson Pharmaceuticals is voluntarily recalling one lot of Propafenone HCL after it discovered that the drug, which is used to irregular heartbeats, may contain more of the active ingredient than it should. The lot in question was shipped to customers between October 15 and November 26, 2008. Report

Suggested Articles

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.

Pfizer's Upjohn has reached a deal to exclusively supply generic Viagra to telehealth provider Roman as the company prepares to merge with Mylan.